Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Cassava Sciences Inc
(NQ:
SAVA
)
29.00
-0.58 (-1.96%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Cassava Sciences Inc
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
20
21
Next >
Benzinga's Daily Brief On Trending Tickers For April 19, 2022: Plug Power, Twitter, Cassava Sciences And More
April 19, 2022
Benzinga’s “Daily Brief On Trending Tickers” features top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news items...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 19, 2022
Gainers Checkmate Pharmaceuticals (NASDAQ:CMPI) shares increased by 331.5% to $10.4 during Tuesday's pre-market session. The market value of their outstanding shares...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
April 19, 2022
Good morning! It's time to start off another busy day of trading with a dive into the biggest pre-market stock movers for Tuesday!
Via
InvestorPlace
23 Stocks Moving in Tuesday's Pre-Market Session
April 19, 2022
Gainers ToughBuilt Industries, Inc. (NASDAQ: TBLT) rose 44.9% to $0.2125 in pre-market trading as the company posted a narrower FY21 loss. Sharps Technology, Inc. (NASDAQ: STSS...
Via
Benzinga
Keep an Eye on $60 as a Target Price for Cassava Sciences
February 07, 2022
As long as you're using a moderate position size, it's fine to hold SAVA stock as it has a tendency to move fast and far from time to time.
Via
InvestorPlace
How Is The Market Feeling About Cassava Sciences Inc?
April 13, 2022
Cassava Sciences Inc's (NASDAQ:SAVA) short percent of float has fallen 3.25% since its last report. The company recently reported that it has 10.93 million shares sold short,...
Via
Benzinga
Cassava Sciences Is Worth Considering After Hitting Its Latest Trough
April 11, 2022
The company has no debt and is cash rich. If it receives FDA approval for its Simufilam drug, the SAVA stock price will catapult.
Via
InvestorPlace
51 Biggest Movers From Yesterday
April 06, 2022
Gainers Sunshine Biopharma, Inc. (NASDAQ: SBFM) shares surged 148.2% to close at $5.61 on Tuesday after the company announced that two of its designed mRNA molecules are...
Via
Benzinga
This Is What Whales Are Betting On Cassava Sciences
February 01, 2022
Someone with a lot of money to spend has taken a bearish stance on Cassava Sciences (NASDAQ:SAVA). And retail traders should know. We noticed this today when the big position showed up on publicly...
Via
Benzinga
Dear SOFI Stock Fans, Mark Your Calendars for May 1
April 05, 2022
SoFi Technologies (SOFI) stock is slipping on Tuesday and may see further falls this week ahead of student loan moratorium news.
Via
InvestorPlace
This Is What Whales Are Betting On Cassava Sciences
April 05, 2022
A whale with a lot of money to spend has taken a noticeably bullish stance on Cassava Sciences. Looking at options history for Cassava Sciences (NASDAQ:SAVA) we detected 14 strange trades.
Via
Benzinga
Why Is Cassava Sciences (SAVA) Stock Down Today?
April 05, 2022
Cassava Sciences (SAVA) stock is falling on Tuesday as investors react to a recent fireside chat held by CEO Remi Barbier.
Via
InvestorPlace
Here's How Much You Would Have Made Owning Cassava Sciences Stock In The Last 5 Years
April 04, 2022
Cassava Sciences (NASDAQ:SAVA) has outperformed the market over the past 5 years by 29.74% on an annualized basis producing an average annual return of 43.85%. Currently, Cassava Sciences has a market...
Via
Benzinga
Risk-on Biotech Investors Should Buy Cassava Sciences
March 30, 2022
SAVA stock is volatile but worthwhile after opinion shifts in its favor. Remember, it has a blockbuster Alzheimer's drug nearing launch.
Via
InvestorPlace
Here's How Much $100 Invested In Cassava Sciences 5 Years Ago Would Be Worth Today
March 16, 2022
Cassava Sciences (NASDAQ:SAVA) has outperformed the market over the past 5 years by 26.48% on an annualized basis. Buying $100 In SAVA: 5 years ago, an investor could have...
Via
Benzinga
Keep Risk in Mind With Cassava Sciences Stock, but Don’t Dismiss Upside Potential
March 15, 2022
A recent admission by management underscores the need to make SAVA stock, at best, a small, speculative position in your portfolio.
Via
InvestorPlace
Cassava Sciences Is in a Bleak Midwinter Waiting for Spring and Better Days
March 03, 2022
SAVA stock is driven by updates on clinical Phase 3 trials and lots of irrationality. Meanwhile, an FDA approval may take quite some time.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
March 02, 2022
Gainers Eargo (NASDAQ:EAR) shares rose 10....
Via
Benzinga
Why Cassava Sciences Is Still a High-Risk Play
February 25, 2022
As it's not set in stone that Cassava Sciences will be able to bring simulfilam to market, you should approach SAVA stock cautiously.
Via
InvestorPlace
23 Stocks Moving in Wednesday's Pre-Market Session
February 23, 2022
Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) rose 64.9% to $2.54 in pre-market trading after gaining around 5% on Tuesday. Roth Capital recently initiated coverage on the...
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
February 18, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Check Out What Whales Are Doing With SAVA
February 11, 2022
Someone with a lot of money to spend has taken a bearish stance on Cassava Sciences (NASDAQ:SAVA). And retail traders should know. We noticed this today when the big position showed up on publicly...
Via
Benzinga
Benzinga's Daily Brief On Trending Tickers For Feb. 11, 2022: Cassava Sciences, Cleveland Cliffs, GameStop, and More
February 11, 2022
Benzinga’s “Daily Brief On Trending Tickers” highlights top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news...
Via
Benzinga
$1000 Invested In This Stock 5 Years Ago, Would Be Worth This Much
February 11, 2022
Cassava Sciences (NASDAQ:SAVA) has outperformed the market over the past 5 years by 53.42% on an annualized basis.
Via
Benzinga
Cassava Sciences Whale Trades Spotted
February 09, 2022
Someone with a lot of money to spend has taken a bullish stance on Cassava Sciences (NASDAQ:SAVA). And retail traders should know. We noticed this today when the big position showed up on publicly...
Via
Benzinga
Does Cassava Sciences and Its Alzheimer’s Drug Really Have What It Takes?
February 08, 2022
Can Cassava Sciences' Simufilam drug really treat Alzheimer's? Who really knows. SAVA stock is pure speculation either way.
Via
InvestorPlace
5 Short Squeeze Candidates To Watch: Vinco Ventures, TSR Inc, Biofrontera And More
February 07, 2022
Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move. A short squeeze can occur when a heavily shorted stock rises in value instead of falling....
Via
Benzinga
The End Result May Be Worth the Wait With Cassava Sciences Stock
February 03, 2022
SAVA stock will continue to trade sideways until the moment of truth arrives for its drug candidate Simufilam.
Via
InvestorPlace
Short Squeeze Activity: New Players, Same Game, Different Results
February 01, 2022
Short squeezes will remain a big story in the financial news media until heavily shorted stocks that have been pushed up by individual investors come crashing back to earth.
Via
Talk Markets
10 Health Care Stocks Whale Activity In Today's Session
February 01, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
20
21
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.